Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

According to CVS Health, both macro and company-specific factors resulted in the challenges within the Aetna business. This ...

CVS Health reported mixed third-quarter results as higher medical ... reflecting seniors who are returning to hospitals to ...

CVS Health on Friday replaced CEO Karen Lynch ... and the company’s shares soared as it benefited from its role in the COVID-19 pandemic recovery. Wall Street analysts have said the company ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

But please don't shop at CVS at all for medications. They're making all their profits off flu vaccinations and Covid-19 vaccinations. If they don't get their vaccinations, they go somewhere else.

especially during the COVID-19 pandemic" and her efforts to turn CVS Health into a technology-driven health care company. The leadership transition comes shortly after CVS Health cut its 2024 ...

CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising ...

VA officials recently recorded their millionth diagnosed COVID-19 case. (Ted S. Warren/AP) Veterans Affairs medical officials ...

CVS replaces its CEO on Friday and cut its third ... The Details: The end of the COVID-19 public health emergency triggered significant changes to Medicaid coverage, including the end of the ...

CVS also withdrew its 2024 profit forecast and ... Lynch had served as CEO since 2021 and led the company through the Covid-19 pandemic, overseeing the rollout of in-store vaccinations.

CVS stock has lost nearly 26% of its value this year due to multiple cuts to the firm's annual profit forecast. Karen Lynch begins her role as CEO in the midst of the COVID-19 pandemic.